COVAX y el acceso equitativo a las vacunas contra la COVID-19

Translated title of the contribution: COVAX and equitable access to COVID-19 vaccines

Katelyn J. Yoo, Akriti Mehta, Joshua Mak, David Bishai, Collins Chansa, Bryan Patenaude

Research output: Contribution to journalArticlepeer-review

Abstract

Objective To evaluate equity in the allocation and distribution of vaccines for coronavirus disease 2019 (COVID-19) to countries and territories participating in the COVID-19 Vaccines Global Access (COVAX) Facility. Methods We used publicly available data on the numbers of COVAX vaccine doses allocated and distributed to 88 countries and territories qualifying for COVAX-sponsored vaccine doses and 60 countries self-financing their vaccine doses facilitated by COVAX. We conducted a benefit–incident analysis to examine the allocation and distribution of vaccines based on countries’ gross domestic product (GDP) per capita. We plotted cumulative country-level per capita allocation and distribution of COVID-19 vaccines from COVAX against the ranked per capita GDP of the countries and territories to generate a measure of the equity of COVAX benefits. Findings By 23 January 2022 the COVAX Facility had allocated a total of 1 678 517 990 COVID-19 vaccine doses, of which 1 028 291 430 (61%) doses were distributed to 148 countries and territories. Taking account of COVAX subsidies, we found that countries and territories with low per capita GDP benefited more than higher-income countries in the numbers of vaccines. The benefits increased further when the analysis was adjusted by population age group (aged 65 years and older). Conclusion The COVAX Facility is helping to balance global inequities in the allocation and distribution of COVID-19 vaccines. However, COVAX alone has not been enough to reverse the inequality of total COVID-19 vaccine distribution. Future studies could examine the equity of all COVID-19 vaccine allocation and distribution beyond the COVAX-facilitated vaccines.

Translated title of the contributionCOVAX and equitable access to COVID-19 vaccines
Original languageSpanish
Pages (from-to)315-328
Number of pages14
JournalBulletin of the World Health Organization
Volume100
Issue number5
DOIs
StatePublished - May 1 2022

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'COVAX and equitable access to COVID-19 vaccines'. Together they form a unique fingerprint.

Cite this